Peregrine Capital Management LLC Has $4.78 Million Stock Position in Cabot Corporation $CBT

Peregrine Capital Management LLC increased its stake in Cabot Corporation (NYSE:CBT) by 14.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,669 shares of the specialty chemicals company’s stock after acquiring an additional 7,965 shares during the quarter. Peregrine Capital Management LLC’s holdings in Cabot were worth $4,775,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. GAMMA Investing LLC lifted its stake in Cabot by 26.1% in the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock valued at $141,000 after buying an additional 352 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Cabot by 9.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,850 shares of the specialty chemicals company’s stock valued at $819,000 after buying an additional 819 shares during the period. KBC Group NV lifted its stake in Cabot by 31.5% in the first quarter. KBC Group NV now owns 2,690 shares of the specialty chemicals company’s stock valued at $224,000 after buying an additional 644 shares during the period. Leeward Investments LLC MA lifted its stake in Cabot by 13.3% in the first quarter. Leeward Investments LLC MA now owns 181,619 shares of the specialty chemicals company’s stock valued at $15,100,000 after buying an additional 21,373 shares during the period. Finally, Lightrock Netherlands B.V. lifted its stake in Cabot by 74.8% in the first quarter. Lightrock Netherlands B.V. now owns 118,644 shares of the specialty chemicals company’s stock valued at $9,881,000 after buying an additional 50,778 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Stock Down 0.1%

Shares of NYSE:CBT opened at $71.00 on Wednesday. The company has a market capitalization of $3.78 billion, a PE ratio of 9.28 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41. The business has a fifty day moving average price of $76.20 and a two-hundred day moving average price of $76.34. Cabot Corporation has a 1 year low of $66.50 and a 1 year high of $117.46.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The firm had revenue of $923.00 million during the quarter, compared to the consensus estimate of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on CBT shares. Mizuho lowered their target price on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research report on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. Finally, UBS Group set a $82.00 price target on Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus target price of $85.00.

Insider Transactions at Cabot

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the company’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the transaction, the chief executive officer owned 361,518 shares in the company, valued at $28,661,147.04. This represents a 24.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.03% of the stock is owned by company insiders.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.